Biotechnology

#AI #Assay development optimisation & technology #Automation / robotics #Biotechnology #Lab automation

Automation, AI and advancing the adjacent possible

Markus Gershater, CSO and Co-Founder of Synthace discusses how technologies such as AI and automation are helping advance biotech and drug discovery.  On June 5th, 1833, Charles Babbage presented a small working part of his “Difference Engine No 1” to a group of interested onlookers. Sitting in the audience was Ada Lovelace, a… Read More

#Exclusive Content

#Automation / robotics #Biotechnology #Drug discovery #Drug screening #ELRIG #Events #Life sciences

Comment: Join the science revolution at Drug Discovery 2022 

ELRIG CEO Sanj Kumar tells readers how they can access the most exciting research and find the latest technologies to propel their projects forward at this year’s Drug Discovery 2022  At ELRIG, our purpose is to support researchers in the life sciences and drug discovery communities to learn, share, innovate,… Read More

#Exclusive Content #Opinion

Mosquito
#Biotechnology #Investment #Malaria

Malaria specialists secure $1.5m investment round  

US biotechnology start-up LivFul has secured a $1.5m investment to expand its work saving lives from malaria and other insect-borne diseases, and to support the company’s growth plans.    The company’s major markets are now opening up following the pandemic, with interest in Livful’s Enhanced Insect Repellent ramping up. Livful is… Read More

#Business & Investment #News

Cell therapy platform
#Automation / robotics #Biotechnology #Cell and gene therapy #Cell therapy

Platform enables cell therapy commercialisation

Terumo Blood and Cell Technologies (BCT) has launched the Quantum Flex Cell Expansion System, a bioreactor platform that supports process development through to commercial manufacturing for the cell and gene therapy (CGT) sector.   Responding to the industry’s need for earlier automation to potentially limit additional and… Read More

#News

#Automation / robotics #Biotechnology #Cell therapy #Novel candidates

Ori Biotech and CTMC accelerate novel cell therapy delivery 

Ori Biotech and the Cell Therapy Manufacturing Center (CTMC) have partnered to accelerate process development, clinical implementation, and commercialisation of novel cell therapies.   The partnership will combine Ori’s technology platform with CTMC’s manufacturing capabilities and, in the first instance, will focus on a cell therapy invented by Dr Sattva Neelapu,… Read More

#Business & Investment #News

#AI #Biotechnology #Collaboration #Drug discovery #Pfizer

Pfizer and CytoReason collaborate to bolster AI in drug discovery

Pfizer has extended its multi-year partnership with CytoReason to use CytoReason’s artificial intelligence (AI) technology for Pfizer’s drug development programs.   Pfizer will make a $20 million equity investment, have options to license CytoReason’s platform and disease models, and fund supplementary project support. This deal which has the potential to be worth up… Read More

#Business & Investment #News

Chinese flag
#Biotechnology #Drug development #Drug discovery #Podcast

Podcast: China’s opportunities for global drug discovery breakthroughs

This is the latest episode of the free DDW podcast, “China’s opportunities for global drug discovery breakthroughs”. It covers three articles written for Volume 22, Issue 4 – Fall 2021 of DDW, narrated by DDW Multimedia Editor Megan Thomas. They are called “Is China entering a new phase for… Read More

#News

#AI #Biotechnology #Pharma

Making its mark: AI in drug discovery 

The concept of Artificial Intelligence (AI) never fails to stimulate and in drug discovery the possibilities it presents, the potential it holds, are always thought-provoking, says DDW Publishing Director Lu Rahman.  The simulation of human intelligence processes by machines finds itself at an exciting moment for use within the drug… Read More

#Exclusive Content #Opinion #Trends & Analysis

#AI / data analytics / healthtech / informatics #Biotechnology

Algorithm uncovers the secrets of cell factories

Drug molecules and biofuels can be made to order by living cell factories, where biological enzymes do the job. Now researchers at Chalmers University of Technology have developed a computer model that can predict how fast enzymes work, making it possible to find the most efficient living factories, as well… Read More

#News

#Biopharma #Biotechnology #CDMO #Drug development

Why project management holds the key to efficient drug development

Listen to this article on the DDW Podcast: Ian Hollingsworth, Associate Director of product development at Boyds, the global drug development consultancy, explains the benefits to the drug development lifecycle of building strong partnerships with external consultants, and when and how to get the best from them. Everyone can benefit from… Read More

#Exclusive Content

#Biotechnology #Clinical trials #Innovate UK #Psychedelics

Awakn Life Sciences receives UK backing for ketamine therapy  

Biotechnology company Awakn Life Sciences has received funding from Innovate UK to help it advance its ketamine-assisted therapy programme to market in the UK and US.   Awakn Life Sciences has developed a ketamine-assisted therapy programme for treating alcohol use disorder (AUD). The company plans to work with… Read More

#News

#Biotechnology #Cell therapy #Narrated podcasts #Oncology

The pursuit of better cancer treatments

This is the latest episode of the free narrated DDW podcast, “The pursuit of better cancer treatments”. It covers two narrated article written for Volume 22, Issue 3 –Summer 2021 of DDW. They are called “The personal touch: the scientist making an impact in cancer research” and… Read More

#Podcasts

#Biotechnology #Drug delivery #Immunotherapy

Calidi granted US patent for immunotherapy platform

Biotechnology company Calidi Biotherapeutics has been granted a US patent for its SuperNova (SNV) technology platform. Calidi’s SNV platform is composed of allogeneic, adipose-derived mesenchymal stem cells (AD-MSC) loaded with an oncolytic agent. The company aims to use it in combination with various immunotherapy agents, including blocking antibodies. The SNV platform is designed to shield oncolytic viral payloads from the… Read More

#News

#AI #Biotechnology #Clinical trials #mRNA

Talking tech in 2022

Listen to this article on the DDW Podcast: With Covid-19 taking so much of the drug discovery and development’s focus over the last two years, it has been easy to overlook other areas within the sector that deserve our attention. With Q1 on its way out, Lu Rahman highlights the technology… Read More

#Exclusive Content

#Alzheimer's #Biotechnology #Mouse models #Neurodegenerative disorders

Novel drug effective in a mouse model of Alzheimer’s disease

Neuro-Bio, a biotechnology company developing a first-in-class treatment for neurodegenerative disease, has found its new drug candidate effectively treats the signs of neurodegeneration in a mouse model of Alzheimer’s disease. Publishing their work in Alzheimer’s & Dementia: Translational Research & Clinical Interventions (TRCI)… Read More

#News